1)Heparinization肝素化
1.Aim To study the LDPE surface heparinization with plasma initiation technique, and antithrombogenicity and tissue compatibility of heparinizing LDPE surface.目的研究等离子体引发低密度聚乙烯（ＬＤＰＥ）表面肝素化以及肝素化ＬＤＰＥ表面抗凝血性和组织相容性。
2.The in vitro blood compatibility of the TLM alloy specimens with and without heparinization treatments was evaluated by the contact angle test, the hemolysis test and investigation of their platelet adhesion behavior.利用XRD、SEM和EDS研究了TiO2薄膜的相结构和表面特性;通过测定材料表面的接触角、溶血率和血小板黏附行为对肝素化TLM合金的血液相容性进行分析、评价。
2)heparinized肝素化
1.Study on the Modification Surface Material of Heparinized Polyurethane;肝素化聚氨酯表面修饰材料的研究
2.Blood compatibility of heparinized polyethersulfone(H-PES),synthesized by chemical modification,was studied in contrasting with polyethersulfone(PES),polyetherurethane(PEU),GAMBRO.目的:以聚醚砜(PES)、聚氨酯(PEU)、聚乙烯(GAMBRO)作为对比,对肝素化聚醚砜材料(H-PES)的血液相容性进行了研究。
3.The main research target is to study the process and technics of sulfonated, aminated and heparinized , biocompatibility and material’s mechanical property.本文研究工作的目的是以聚醚砜(PES)为基材,采用整体肝素化方法开发研究用于与血液接触的器官制造及设备如人工心脏、透析膜等的生物材料,对材料的改性磺化、胺化、肝素化等制备过程与机制、材料的表征、材料的血液相容性及力学性能进行了较系统的研究。
3)heparinize['hep?rinaiz]肝素化
1.The blend film was prepared by blending the heparinized collagen and aqueous of silk fibroin, and glutaraldehyde was used as a coupling agent in order to enhance its mechanical properties of blend film.将肝素化胶原与丝素溶液共混,制备了肝素化胶原/丝素共混膜,并采用戊二醛作为交联剩,以提高共混膜的机械性能。
4)non-heparinization无肝素化
5)Non-heparinized非肝素化
1.Conclusion:Non-heparinized could avoid the effect of anticoagulants on blood gas analysis and electrolyte,it can also save time,cost,reduce the nurse workload,simplify working procedures and save time for patient salvage.目的:探讨非肝素化注射器采血对动脉血气分析和电解质测定值的影响。
英文短句/例句
1.Study on non-heparinized arterial blood gas analysis syringe acquisition非肝素化注射器采集动脉血气分析的研究
2.Association of serum vaspin with liver fibrosis of nonalcoholic fatty liver disease and insulin resistance内脂素与非酒精性脂肪肝肝纤维化及胰岛素抵抗的关系
3.Relationship Between Adiponectin and Hepatic Fibrosis Markers Expressions as well as Insulin Resistance Index in patients with Non-alcoholic Fatty Liver Disease脂联素与非酒精性脂肪肝肝纤维化及胰岛素抵抗的关系
4.Infuluence of Electroacupuncture on Non-Alcoholic Fatty Liver Cytochrome P4502E1 Expression and Owidation s Impact;电针对非酒精性脂肪肝肝细胞色素P450 2E1表达及氧化抗氧化的影响
5.Influence of Electroacupuncture on Hepatic Cytochrome P4501A1 Expression and Lipid Peroxidation in Nonalcoholic Fatty Liver Rats电针对非酒精性脂肪肝大鼠肝细胞色素P4501A1和脂质过氧化的影响
6.Correlative Study of Serum Leptin and Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease非酒精性脂肪肝患者血清瘦素水平与肝纤维化关系研究
7.Analysis of Serum Adiponectin Level and Related Factors in Nonalcoholic Fatty Liver Disease非酒精性脂肪性肝病患者血清脂联素变化及其相关因素分析
8.Changes in serum leptin and adiponectin levels in patients with nonalcoholic fatty liver disease非酒精性脂肪性肝病患者血清瘦素、脂联素的变化
9.Relationship between plasma adiponectin and leptin levels with nonalcoholic fatty liver disease血浆脂联素及瘦素水平在非酒精性脂肪性肝病的变化及意义
10.Change of serum leptin and soluble leptin receptor in nonalcoholic fatty liver disease patients非酒精性脂肪肝病患者血清瘦素及可溶性瘦素受体的变化
11.The leptin,TNF-α and adiponectin in blood and liver of nonalcoholic fatty liver disease in rats非酒精性脂肪肝血清及肝组织瘦素、肿瘤坏死因子α、脂联素的变化及意义
12.Effects of leptin and transforming growth factor β_1 on liver fibrosis in patients with nonalcoholic steatohepatitis瘦素和转化生长因子β_1对非酒精性脂肪性肝炎患者肝纤维化的影响
13.XIEZHOU HUAYU PRESCRIPTION ON LIVER PIGMENT P450ⅡE_1 EXPRESSION AND LIPID PEROXIDATION OF RATS WITH NON-ALCOHOLIC FATTY LIVER泄浊化瘀方对非酒精性脂肪肝大鼠肝细胞色素P450ⅡE_1表达及脂质过氧化的影响
14.The incidence and risk factors of chemotherapy-induced liver disease of the patients with acute non-lymphocytic leukemia急性非淋巴细胞白血病化疗肝损伤发生率及其相关因素研究
15.Relationship Between Serum Leptin and Fatty Liver Induced by High-fat-diet in Rats高脂饮食致非酒精性脂肪肝大鼠血清瘦素水平的变化
16.Expression of PPARα and Changes in Lipid Metabolism and Insulin level in the Nonalcoholic Fatty Liver Disease Rats非酒精性脂肪肝大鼠PPARα基因表达及脂代谢和胰岛素水平的变化
17.Effect of Xiaoyu Huatan Yin on insulin resistance of nonalcoholic fatty liver disease消瘀化痰饮对非酒精性脂肪肝胰岛素抵抗的影响
18.Effect of rosiglitazone on liver fibrosis and insulin resistance in non-alcoholic fatty liver disease罗格列酮对非酒精性脂肪肝病纤维化及胰岛素抵抗的影响
相关短句/例句
heparinized肝素化
1.Study on the Modification Surface Material of Heparinized Polyurethane;肝素化聚氨酯表面修饰材料的研究
2.Blood compatibility of heparinized polyethersulfone(H-PES),synthesized by chemical modification,was studied in contrasting with polyethersulfone(PES),polyetherurethane(PEU),GAMBRO.目的:以聚醚砜(PES)、聚氨酯(PEU)、聚乙烯(GAMBRO)作为对比,对肝素化聚醚砜材料(H-PES)的血液相容性进行了研究。
3.The main research target is to study the process and technics of sulfonated, aminated and heparinized , biocompatibility and material’s mechanical property.本文研究工作的目的是以聚醚砜(PES)为基材,采用整体肝素化方法开发研究用于与血液接触的器官制造及设备如人工心脏、透析膜等的生物材料,对材料的改性磺化、胺化、肝素化等制备过程与机制、材料的表征、材料的血液相容性及力学性能进行了较系统的研究。
3)heparinize['hep?rinaiz]肝素化
1.The blend film was prepared by blending the heparinized collagen and aqueous of silk fibroin, and glutaraldehyde was used as a coupling agent in order to enhance its mechanical properties of blend film.将肝素化胶原与丝素溶液共混,制备了肝素化胶原/丝素共混膜,并采用戊二醛作为交联剩,以提高共混膜的机械性能。
4)non-heparinization无肝素化
5)Non-heparinized非肝素化
1.Conclusion:Non-heparinized could avoid the effect of anticoagulants on blood gas analysis and electrolyte,it can also save time,cost,reduce the nurse workload,simplify working procedures and save time for patient salvage.目的:探讨非肝素化注射器采血对动脉血气分析和电解质测定值的影响。
6)Whole Heparinization全身肝素化
延伸阅读
肝素化分子式：CAS号：性质：足量肝素达到全身性适度抗凝的治疗方法。主要用于诊断明确、出血症状严重、病因不能迅速控制的播散性血管内凝血(DIC),以阻止血管内血液凝固的继续发展、纤维蛋白原和其他凝血因子的消耗和继发出血或出血加重。一般采用静脉滴注肝素。使用期间需监测凝血机能,随时调整剂量。肝素的抗凝作用与抗凝血酶III(AT—III)有关,当血浆AT—III活性降低,其作用也相应下降。体外循环、急性肾功能衰竭进行血液透析时也需进行全身性肝素化,不同病情时的肝素化方案各异。
